Coalition for the Advancement of Prosthetic Urology hosts informationallunch
Chicago-Urologists interested in Medicare reimbursement rates for prostheticurology should consider attending an informational lunch hosted by the Coalitionfor the Advancement of Prosthetic Urology (CAPU). John Mulcahy, MD, chairmanof CAPU, which is comprised of leading clinical experts and researchersin prosthetic urology and the nation's leading manufacturers and developersof prosthetic urological devices, will discuss the group's advocacy andoutreach initiatives.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Jonathan E. Rosenberg, MD, discusses the FDA approval of perioperative durvalumab plus enfortumab vedotin and considerations for treatment selection in cisplatin-ineligible MIBC.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.